Close
  Indian J Med Microbiol
 

Figure 4: (a) DNA fragmentation analysis (Lane 1, M = Marker; Lane 2, control DNA; Lane 3 = DNA from benzene-exposed group; Lane 4 = DNA from yellowish brown material treated (Saraca asoca) group and Lane 5 = DNA from Dox-treated group. (b) Comet assay from blood lymphocytes of control (Plate I); benzene-exposed mice (Plate II), acute myeloid leukemia mice treated with yellowish brown material (Catechin) (Plate III) and treated with doxorubicin (Plate IV) showing comet tails

Figure 4: (a) DNA fragmentation analysis (Lane 1, M = Marker; Lane 2, control DNA; Lane 3 = DNA from benzene-exposed group; Lane 4 = DNA from yellowish brown material treated (<i>Saraca asoca</i>) group and Lane 5 = DNA from Dox-treated group. (b) Comet assay from blood lymphocytes of control (Plate I); benzene-exposed mice (Plate II), acute myeloid leukemia mice treated with yellowish brown material (Catechin) (Plate III) and treated with doxorubicin (Plate IV) showing comet tails